buprenorphine + naloxone
Commercial- Indications
- Opioid use disorder
Company intelligence / Profile preview
Bicycle Health has served over 40,000 patients across the U.S. with its evidence-based telehealth model for opioid use disorder. Its clinical outcomes include an industry-leading patient retention rate of ~80% at 90 days and a urine drug screen falsification rate below industry averages. The company reached operating profitability in Q4 2024 and continues to expand access through partnerships with major payors and health systems. Published data show best-in-class outcomes compared to traditional in-person clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bicycle Health.